arBtrage CAPITALIZING MARKETS checking… Sign in

MacroGenics, Inc.

MGNX Health Care Biotechnology: Pharmaceutical Preparations
$3.91
▼ -8.0% Today
as of Jun 7, 07:21 ET
Last 30 days +29.90% Apr 28 → Jun 05
$2.81 $3.27 $3.74 $4.20 $4.66 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.27
High
$4.29
Low
$3.88
Volume
$559,354
Avg Vol
$1M
Mkt Cap
$268M
P/E (TTM)
Beta
52w High
$4.64
52w Low
$1.19
Div Yield
Shares Out
$64M

Overview

52-week range
$1.19
$4.64
79% of range
Avg surprise (last 2)
-4.2%
Avg reaction (last 2)
-2.6%
0% positive
Latest IV / EM
125%
EM ±17.3% · $4 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.89$-0.44$0.02$0.47$0.92 Actual $0.92Actual $0.28Actual $-0.84Actual $-0.89Actual $0.90Actual $-0.65Est $-0.61Actual $-0.57Actual $0.27Actual $-0.58Est $-0.57 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-56M$-13M$30M$73M$116M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.58 $-0.57 -1.8% +10.8% -2.0% earnings
Tue Sep 30, 2025Sep 2025 $0.27 financials
Mon Jun 30, 2025Jun 2025 $-0.57 financials
Tue May 13, 2025Mar/2025 $-0.65 $-0.61 -6.6% -3.1% earnings
Mon Sep 30, 2024Sep 2024 $0.90 financials
Sun Jun 30, 2024Jun 2024 $-0.89 financials
Sun Mar 31, 2024Mar 2024 $-0.84 financials
Sat Sep 30, 2023Sep 2023 $0.28 financials
Fri Jun 30, 2023Jun 2023 $0.92 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$21M$73M$22M$13M$111M$11M
Cost of revenue$0$0$0$168,000$176,000
Gross profit
Operating income$-33M$19M$-37M$-43M$54M$-58M
Net income$-37M$17M$-36M$-41M$56M$-56M
EPS (diluted)$-0.58$0.27$-0.57$-0.65$0.90$-0.89

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$67M$57M$80M$131M$146M$183M$180M$84M
Inventory$9M$8M$9M$9M$9M$0$3M$1M
Total current assets$183M$220M$232M$205M$182M$217M$222M$157M
Total assets$218M$257M$271M$245M$225M$262M$264M$201M
Long-term debt
Total liabilities$197M$201M$204M$199M$145M$146M$144M$143M
Total equity$21M$56M$67M$47M$79M$116M$120M$58M

Implied volatility — last 90 days

119%122%124%127%129% Jun 07 — IV 125% · EM ±17.3%

Sector peers